Evaluation of impaired β-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 676-684

  Sever, Dror ^a   Eldor, Roy ^a   Sadoun, Gadi ^a   Amior, Livnat ^a   Dubois, Daniele ^b   Boitard, Christian ^b   Aflalo, Claude ^c   Melloul, Danielle ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b INSERM   (France)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cytokines; Diabetes mellitus; Firefly luciferase; cell mass

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOKINE; DOXYCYCLINE; FIREFLY LUCIFERASE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL FUNCTION; CELL VOLUME; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 79551635096     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-158121     Document Type: Article

References (42)

1. Amos, A. F., McCarty, D. J., and Zimmet, P. (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 14(Suppl. 5), S1-S85
2. Eizirik, D. L., Colli, M. L., and Ortis, F. (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5, 219-226
3. Mathis, D., Vence, L., and Benoist, C. (2001) beta-Cell death during progression to diabetes. Nature 414, 792-798
4. Kay, T. W., Thomas, H. E., Harrison, L. C., and Allison, J. (2000) The beta cell in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol. Metab. 11, 11-15
5. Faideau, B., Larger, E., Lepault, F., Carel, J. C., and Boitard, C. (2005) Role of β-cells in type 1 diabetes pathogenesis. Diabetes 54(Suppl. 2), S87-S96
6. Klinke, D. J., 2nd (2008) Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PLoS ONE 3, e1374
7. Steele, C., Hagopian, W. A., Gitelman, S., Masharani, U., Cavaghan, M., Rother, K. I., Donaldson, D., Harlan, D. M., Bluestone, J., and Herold, K. C. (2004) Insulin secretion in type 1 diabetes. Diabetes 53, 426-433
8. Pipeleers, D., Chintinne, M., Denys, B., Martens, G., Keymeulen, B., and Gorus, F. (2008) Restoring a functional beta-cell mass in diabetes. Diabetes Obes. Metab. 10(Suppl. 4), 54-62
9. Paty, B. W., Bonner-Weir, S., Laughlin, M. R., McEwan, A. J., and Shapiro, A. M. (2004) Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 77, 1133-1137
10. Lin, M., Lubag, A., McGuire, M. J., Seliounine, S. Y., Tsyganov, E. N., Antich, P. P., Sherry, A. D., Brown, K. C., and Sun, X. (2008) Advances in molecular imaging of pancreatic beta cells. Front. Biosci. 13, 4558-4575
11. Gimi, B., Leoni, L., Oberholzer, J., Braun, M., Avila, J., Wang, Y., Desai, T., Philipson, L. H., Magin, R. L., and Roman, B. B. (2006) Functional MR microimaging of pancreatic beta-cell activation. Cell. Transplant. 15, 195-203
12. Antkowiak, P. F., Tersey, S. A., Carter, J. D., Vandsburger, M. H., Nadler, J. L., Epstein, F. H., and Mirmira, R. G. (2009) Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am. J. Physiol. Endocrinol. Metab. 296, E573-E578
13. Anderson, M. S., and Bluestone, J. A. (2005) The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447-485
14. Denis, M. C., Mahmood, U., Benoist, C., Mathis, D., and Weissleder, R. (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 101, 12634-12639
15. Turvey, S. E., Swart, E., Denis, M. C., Mahmood, U., Benoist, C., Weissleder, R., and Mathis, D. (2005) Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J. Clin. Invest. 115, 2454-2461
16. Virostko, J., Chen, Z., Fowler, M., Poffenberger, G., Powers, A. C., and Jansen, E. D. (2004) Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants. Mol. Imaging 3, 333-342
17. Fowler, M., Virostko, J., Chen, Z., Poffenberger, G., Radhika, A., Brissova, M., Shiota, M., Nicholson, W. E., Shi, Y., Hirshberg, B., Harlan, D. M., Jansen, E. D., and Powers, A. C. (2005) Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 79, 768-776
18. Park, S. Y., Wang, X., Chen, Z., Powers, A. C., Magnuson, M. A., Head, W. S., Piston, D. W., and Bell, G. I. (2005) Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 43, 80-86
19. Chen, X., Zhang, X., Larson, C. S., Baker, M. S., and Kaufman, D. B. (2006) In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 81, 1421-1427
20. Smith, S. J., Zhang, H., Clermont, A. O., Powers, A. C., Kaufman, D. B., Purchio, A. F., and West, D. B. (2006) In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol. Imaging 5, 65-75
21. Park, S. Y., and Bell, G. I. (2009) Noninvasive monitoring of changes in pancreatic beta-cell mass by bioluminescent imaging in MIP-luc transgenic mice. Horm. Metab. Res. 41, 1-4
22. Eldor, R., Yeffet, A., Baum, K., Doviner, V., Amar, D., Ben-Neriah, Y., Christofori, G., Peled, A., Carel, J. C., Boitard, C., Klein, T., Serup, P., Eizirik, D. L., and Melloul, D. (2006) Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl. Acad. Sci. U. S. A. 103, 5072-5077
23. Aflalo, C. (1991) Biologically localized firefly luciferase: a tool to study cellular processes. Intl. Rev. Cytol. 130, 269-323
24. Thebault-Baumont, K., Dubois-Laforgue, D., Krief, P., Briand, J. P., Halbout, P., Vallon-Geoffroy, K., Morin, J., Laloux, V., Lehuen, A., Carel, J. C., Jami, J., Muller, S., and Boitard, C. (2003) Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest. 111, 851-857
25. Honigman, A., Zeira, E., Ohana, P., Abramovitz, R., Tavor, E., Bar, I., Zilberman, Y., Rabinovsky, R., Gazit, D., Joseph, A., Panet, A., Shai, E., Palmon, A., Laster, M., and Galun, E. (2001) Imaging transgene expression in live animals. Mol. Ther. 4, 239-249
26. Aflalo, C. (1997) Localized firefly luciferase probes ATP at the surface of mitochondria. J. Bioenerg. Biomembr. 29, 549-559
27. Lundin, A. (2000) Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol. 305, 346-370
28. Mauricio, D., and Mandrup-Poulsen, T. (1998) Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47, 1537-1543
29. Achenbach, P., Bonifacio, E., Koczwara, K., and Ziegler, A. G. (2005) Natural history of type 1 diabetes. Diabetes 54(Suppl. 2), S25-S31
30. Sherry, N. A., Tsai, E. B., and Herold, K. C. (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54(Suppl. 2), S32-S39
31. Virostko, J., Radhika, A., Poffenberger, G., Chen, Z., Brissova, M., Gilchrist, J., Coleman, B., Gannon, M., Jansen, E. D., and Powers, A. C. (2009) Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Mol. Imaging Biol. 12, 42-53
32. Shimada, A., Charlton, B., Taylor-Edwards, C., and Fathman, C. G. (1996) Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45, 1063-1067
33. Meier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., and Butler, P. C. (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48, 2221-2228
34. Meier, J. J., Lin, J. C., Butler, A. E., Galasso, R., Martinez, D. S., and Butler, P. C. (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49, 1838-1844
35. Dotta, F., Censini, S., van Halteren, A. G., Marselli, L., Masini, M., Dionisi, S., Mosca, F., Boggi, U., Muda, A. O., Prato, S. D., Elliott, J. F., Covacci, A., Rappuoli, R., Roep, B. O., and Marchetti, P. (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U. S. A. 104, 5115-5120
36. Reddy, S., Chai, R. C., Rodrigues, J. A., Hsu, T. H., and Robinson, E. (2008) Presence of residual beta cells and coexisting islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study. J. Mol. Histol. 39, 25-36
37. Sreenan, S., Pick, A. J., Levisetti, M., Baldwin, A. C., Pugh, W., and Polonsky, K. S. (1999) Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48, 989-996
38. Sherry, N. A., Kushner, J. A., Glandt, M., Kitamura, T., Brillantes, A. M., and Herold, K. C. (2006) Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55, 3238-3245
39. Strandell, E., Eizirik, D. L., and Sandler, S. (1990) Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. J. Clin. Invest. 85, 1944-1950
40. Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., and Morgan, N. G. (2009) Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173-181
41. Meredith, M., Rabaglia, M. E., Corbett, J. A., and Metz, S. A. (1996) Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes 45, 1783-1791
42. Kawasaki, E., Abiru, N., and Eguchi, K. (2004) Prevention of type 1 diabetes: from the view point of beta cell damage. Diabetes Res. Clin. Pract. 66(Suppl. 1), S27-S32